TGR5 activation promotes energy expenditure, improves endothelial function, and suppresses vascular inflammation, suggesting therapeutic utility for atherosclerosis and metabolic syndrome (Van Nierop et al., 2017). Here, GPBAR1 is linked to metabolic syndrome.